Biotechnology

Pieris Pharmaceuticals Announces Appointments of Chief Financial Officer and Chief Business Officer

October 6, 2021 8:00 AM

BOSTON, MA / ACCESSWIRE / October 6, 2021 / Pieris Pharmaceuticals, Inc. (NASDAQ:PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for respiratory diseases, cancer, and other indications, today announced the promotions of Thomas Bures to Chief Financial Officer and Ahmed Mousa to Chief Business Officer. "Since joining Pieris four years ago, Tom has demonstrated...

Read more

Germany Approves Novel Cell Therapy Extracted from Skin

October 6, 2021 3:50 AM

Germany's Federal Institute for Vaccines and Biomedicines (Paul-Ehrlich-Institut) grants RHEACELL national approval for its cell therapy product AMESANAR(R) for the use in patients with chronic wounds HEIDELBERG, GERMANY / ACCESSWIRE / October 6, 2021 / Chronic wounds not only put great strain on the health system, but also have a major impact on the quality of life of affected patients. RHEACELL, a German biopharmaceutical company focused on...

Read more

Biogravity LLC Opens Microgravity-Focused Laboratory at WMU Innovation Center

October 5, 2021 2:50 PM

INNOVATIONS IN BIOTECH AND CELL DISCOVERY TO USE GRAVITATIONAL UNLOADING KALAMAZOO, MI / ACCESSWIRE / October 5, 2021 / Newly launched microgravity startup www.BioGravityLLC.com has opened their lab at the Western Michigan University Homer Stryker M.D. School of Medicine Innovation Center. Touted as a place to start and grow life science, technology, and engineering ventures, the WMU Innovation Center integrates 69,000-square-feet of...

Read more

Lexaria Oral Nicotine Study NIC-A21-1 Delivers Outstanding Results

October 5, 2021 9:05 AM

DehydraTECH-oral nicotine delivery peaked in bloodstream 10x to 20x faster than controls Peak levels achieved were up to 10x higher than controls KELOWNA, BC / ACCESSWIRE / October 5, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to announce that its recent oral nicotine absorption study NIC-A21-1 revealed that DehydraTECHTM-nicotine delivered...

Read more

Black Bird Biotech Retires Three Separate Convertible Notes with Cash Repayments

October 5, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / October 5, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, announced today that it has repaid approximately $225,000 in remaining indebtedness under three separate convertible notes with cash payments. BBBT's move served to protect shareholders from a potentially significant market overhang attributable to below-market conversion rates. "We took on these...

Read more

CB Scientific, Inc. (CBSC) Announces the Engagement of MaloneBailey, LLP

October 5, 2021 6:00 AM

CBSC begins independent Financial Audit through MaloneBailey, LLP. ESCONDIDO, CA / ACCESSWIRE / October 5, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company") is a provider of remote ECG cardiac monitoring products and services; simple wearable solutions for detecting potentially life-threatening heart arrhythmias in patients with heart-related issues, both domestically and internationally. The company has announced that they...

Read more

Applied UV Continues Successful International Expansion with Installations of Airocide(R) Systems at Multiple Wineries in Mexico

October 4, 2021 8:30 AM

Exclusive distributor has recently installed Airocide® units to help protect winemaking operations MOUNT VERNON, NY / ACCESSWIRE / October 4, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and...

Read more

BioInvent and Transgene to present preclinical data on BT-001 oncolytic virus at SITC 2021

October 1, 2021 9:15 AM

LUND, SE / ACCESSWIRE / October 1, 2021 / BioInvent International (STO:BINV) BioInvent International AB ("BioInvent") (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, and Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announce that they...

Read more

Upcoming Presentation at the World Molecular Imaging Congress to Highlight Mosaic ImmunoEngineering’s Lead Immuno-Oncology and Modular Vaccine Platform COVID-19 Vaccine Candidates

October 1, 2021 8:00 AM

NOVATO, CA / ACCESSWIRE / October 1, 2021 / Mosaic ImmunoEngineering Inc. ("Mosaic" or the "Company"), (OTCQB:CPMV), a development-stage biotechnology company focused on bridging immunology and engineering to develop novel immunotherapies to treat and prevent cancer and infectious diseases, today announced that Nicole F. Steinmetz, Ph.D., acting chief scientific officer and co-founder of Mosaic and the director of the UC San Diego Center for...

Read more

enVVeno Medical Corporation Successfully Completes Rebranding

October 1, 2021 7:02 AM

Company Now Trading Under Ticker Symbol "NVNO" IRVINE, CA / ACCESSWIRE / October 1, 2021 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, announced today that it has successfully completed its rebranding and that its shares are now trading under the ticker symbol "NVNO" on The Nasdaq Capital Market. The Company was formerly called Hancock Jaffe...

Read more

Applied UV Announces Laboratory Results Confirm SteriLumen’s Airocide(R) Kills SARS-CoV-2 (COVID-19 Virus)

September 30, 2021 10:40 AM

MOUNT VERNON, NY / ACCESSWIRE / September 30, 2021 / Applied UV, Inc. (NasdaqCM:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, today announced testing results from an independent third-party laboratory confirming...

Read more

Pressure BioSciences UST Platform Successfully Transforms Neem Oil into a Novel, Highly Potent Nanoemulsion for More Effective Agrochemical Applications

September 30, 2021 9:13 AM

Nanoemulsified Neem Oil Droplets Were Designed to Provide Stable, Water-Miscible Concentrates of this Natural, Environmentally Safe Pesticide for Improved Wholesale and Retail Use SOUTH EASTON, MA / ACCESSWIRE / September 30, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

Read more

Hemogenyx Pharmaceuticals PLC Announces Half-Year Report

September 30, 2021 3:00 AM

Interim Results for the period ended 30 June 2021 LONDON, UK / ACCESSWIRE / September 30, 2021 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the StandardListed biopharmaceutical group developing therapies designed to transform blood disease treatment, announces unaudited interim results for the six-month period ended 30 June 2021. All financial amounts are stated in GBP British pounds unless otherwise indicated. Key Highlights Completed...

Read more

Pressure BioSciences Announces Forward Integration Plans for Ultra Shear Technology Demonstration and Toll Manufacturing Partnerships on U.S. West and East Coasts

September 29, 2021 9:35 AM

Company Flooded with Opportunities to Demo Breakthrough UST Nanoemulsion Benefits and Serve Toll Production Demand in Pharmaceutical, Nutraceutical, and Personal Care Applications SOUTH EASTON, MA / ACCESSWIRE / September 29, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide...

Read more

Applied UV Announces Acquisition of the Assets of KES Science & Technology

September 29, 2021 7:00 AM

Transaction significantly scales air purification product portfolio and customer base Developed for NASA as a patented pathogen killing technology; patents were originally obtained by KES Expands access to food distribution, grocery chains, and fast-growing cannabis market Proprietary photocatalytic oxidation process thoroughly destroys viruses (including COVID-19), bacteria, spores, and fungi Accelerates the strategy to grow revenues through...

Read more

EV Biologics Updates on NFT Minting

September 28, 2021 9:00 AM

NASHVILLE, TN / ACCESSWIRE / September 28, 2021 / EV Biologics Corp, OTC PINK:YECO, today updated shareholders with further details about its NFT and minting progress. Our NFT team has been minting the NFT, designated rEVerie, on the Ghostmarket.io platform, with an estimated completion date this week. The Company will mint 72,253 NFTs on this platform for distribution as a dividend. To our knowledge, this is single biggest NFT minting in...

Read more

Black Bird Biotech Announces Important Wide-Ranging Field Tests of its Disruptive MiteXstreamTM Biopesticide by A Second International Agri-Chemical Distributor Based in the Middle East

September 28, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / September 28, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that an international agri-chemical distributor based in the Middle East is scheduled to begin field testing MiteXstreamTM in October 2021, on numerous crops, including tomato, cucumber, eggplant and leafy greens, as mite populations rise. This distributor noted that, due to the...

Read more

ITOCO Enhances Its Carbon Credit Potential by Increasing Nopal Cactus Plantation Land Areas Under Contract by 40% to a Total of 1,450 Hectares

September 28, 2021 8:00 AM

TORONTO, ON / ACCESSWIRE / September 28, 2021 / ITOCO INC. (OTC PINK:ITMC) is pleased to have received final signatures on an additional 436 hectares of Nopal Cactus Plantations in State of Mexico and Hidalgo State, Mexico from 125 additional farmers. As before, ITOCO has applied to "Verra Standard (VCS)" for the certification of approximately US $750k in Carbon Credits based on the extractive properties of the Nopal Cactus plant vis a vis...

Read more

Pressure BioSciences to Update Investors on Recent Accomplishments, Year-End Goals, Plans for Accelerating Revenue Growth, and Path to Profitability in 2022

September 28, 2021 7:31 AM

Company to Present this Week at the Benzinga Healthcare and Emerging Growth Small Cap Conferences SOUTH EASTON, MA / ACCESSWIRE / September 28, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food &...

Read more

CB Scientific, Inc. (CBSC) Announces the Launch of Direct-to-Consumer Heart Wellness Check-Up Program in Bangkok, Thailand

September 28, 2021 6:00 AM

Mango Wellness Co., Ltd. and My Cardia Thailand Co., Ltd. to begin new remote cardiac monitoring service through pharmacies and clinics in the greater Bangkok market. ESCONDIDO, CA / ACCESSWIRE / September 28, 2021 / CB Scientific. Inc. (OTC PINK:CBSC) ("CBSC" or the "Company"), a provider of remote ECG cardiac monitoring products and services (my-Cam™ monitor and my-Cardia™ cloud-based software portal), both domestically and internationally,...

Read more